Latest Comments

A brighter future for rheumatoid arthritis patients?

A brighter future for rheumatoid arthritis patients?

Will FDA guidance on interchangeability help or hinder biosimilar market growth?

Will FDA guidance on interchangeability help or hinder biosimilar market growth?

Dementia associated with soccer headers

Dementia associated with soccer headers

Pharma marketers must embrace digital or be left in the dark

Pharma marketers must embrace digital or be left in the dark

Merck & Co. weighs in on pharma pricing debate by releasing pricing transparency report

Merck & Co. weighs in on pharma pricing debate by releasing pricing transparency report

Despite Trump's surprising stance, drug prices will continue to rise in the US

Despite Trump's surprising stance, drug prices will continue to rise in the US

Will a focus on oncology bring blockbuster success?

Will a focus on oncology bring blockbuster success?

The emergence of oncology biosimilars

The emergence of oncology biosimilars

What does Brexit mean for medical regulation?

What does Brexit mean for medical regulation?

Is ADHD an American Disorder?

Is ADHD an American Disorder?

Research community applauds new sepsis definition, but many clinicians remain sceptical

Research community applauds new sepsis definition, but many clinicians remain sceptical

CDK4/6 inhibitor rivalry in breast cancer begins

CDK4/6 inhibitor rivalry in breast cancer begins

BMS to have their cake and eat it with Keytruda settlement

BMS to have their cake and eat it with Keytruda settlement

New FDA guidelines aim to mitigate development of antibiotic resistance

New FDA guidelines aim to mitigate development of antibiotic resistance

Roche’s Tecentriq pulls further ahead in metastatic bladder cancer

Roche’s Tecentriq pulls further ahead in metastatic bladder cancer

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Elagolix launch is welcome, but it won't be a cure-all for endometriosis

Elagolix launch is welcome, but it won't be a cure-all for endometriosis

Rule-breakers: rehabilitating wayward clinical researchers

Rule-breakers: rehabilitating wayward clinical researchers

Could copper unlock a new wave of metabolic treatments?

Could copper unlock a new wave of metabolic treatments?